Cannabidiol research for Epilepsy continues to be hindered by Drug Laws

Curtis Howell PURE CBD Leave a Comment

Medical progress for cannabidiol treatments to prevent epilepsy continue to be derailed by drug laws according to a report by New England Journal of Medicine.

According to Daniel Friedman, MD, and Orrin Devinsky, MD, from the NYU Langone Medical Center in New York City a major brain receptor, cannabinoid receptor 1 or CB1, when activated, appears to have anticonvulsant effects. CB1 receptors are activated by tetrahydrocannabinol, the constituent in cannabis that is psychoactive. Animals studies have found that non-psychoactive Cannabidiol (CBD) gives best chance of preventing seizures.

To read more, check out “Cannabinoids in the Treatment of Epilepsy” at:

Brought to you by Visit our blog for more more news, information, and interesting facts about Cannabidiol (CBD).


Leave a Reply